Research programme: mucoregulators - Genaera

Drug Profile

Research programme: mucoregulators - Genaera

Latest Information Update: 08 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Genaera Corporation
  • Class Small molecules
  • Mechanism of Action Mucin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Lung disorders

Most Recent Events

  • 30 Jul 2002 This programme is still in active development
  • 26 Apr 2001 MSI 1953 is one of Genaera's mucoregulator compounds
  • 28 Mar 2001 Magainin Pharmaceuticals is now called Genaera Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top